English
中文
Español
Search
New Chat
Hot Signals
Calendar
Agents
Market
Events
Download App
Language
Novo Market Pulse Today
199 News
NVO Gains 1.28% as Wegovy® Approval Recommendations Boost Investor Confidence
May. 23
Novo Nordisk Shares Plunge 1.51% Following Disappointing CagriSema Trial Results
May. 22
Novo Nordisk (NVO) Gains 1.78% to Close at $45.07 Amid Positive Market Trends
May. 21
Novo Nordisk (NVO) Holds Steady at $44.28 Amid Positive Drug Developments
May. 20
Novo Nordisk Shares Dip 0.82% Amid Competitive Pressures and Ongoing Buyback Program
May. 19
Novo Nordisk Plummets 2.31% Amidst Rising Competition from Eli Lilly
May. 16
Novo Nordisk Closes Down 0.15% Despite Strong Q1 Earnings and Promising Wegovy Data
May. 14
Novo Nordisk (NVO) Rises 1.29% with Strong Trading Volume on May 12, 2026
May. 13
Novo Nordisk Climbs 2.37% to Close at $47.16 Following Strong Q1 Results and Upgraded Guidance
May. 12
Novo Nordisk Climbs 0.59% to Close at $46.07 After Strong Q1 Earnings Report
May. 09
Novo Nordisk (NVO) Rises 1.98% to $45.76 Following Mixed Q1 Earnings Report
May. 07
Novo Nordisk (NVO) Gains 1.08% on May 5, 2026, Amid Positive Market Sentiment
May. 06
Novo Nordisk Stock Climbs 1.16% Ahead of Key Earnings Report and Product Launch
May. 05
Novo Nordisk Soars 4.79% to Close at $42.22 Amidst Earnings Anticipation
May. 01
Novo Nordisk Stock Drops 2.14% Amid Concerns Over Sales Forecast and FDA Warning
Apr. 30
Novo Nordisk Stock Dips 0.07% Amid Revised 2026 Revenue Outlook and Competitive Pressures
Apr. 29
Novo Nordisk Stock Edges Up 0.07% Amid Share Buyback Announcement and Positive Clinical Trial Results
Apr. 28
Novo Nordisk Soars 5.9% Amid Positive Clinical Trial Results and Share Buyback News
Apr. 25
Novo Nordisk (NVO) Drops 1.61% to Close at $38.52 Amidst Lack of News
Apr. 24
Novo Nordisk Stock Dips 0.68% Amid Mixed Market Sentiment and Regulatory Scrutiny
Apr. 23
Load More
NextFin.Al
No Noise, only Signal.
Open App
